Target intelligence / Profile preview

Serpin family G member 1 (SERPING1)

Target
SERPING1
Molecular classification
Serine protease inhibitor (serpin), Enzyme regulator (regulates complement proteins, kallikrein, and factor XIIa)
01

Overview

Serpin family G member 1 (SERPING1) encodes C1 inhibitor (C1-INH), a highly glycosylated plasma protein belonging to the serpin superfamily. C1-INH is a critical regulator of the complement system, modulating classical pathway activation by inhibiting proteases such as C1r, C1s, plasma kallikrein, and activated factor XII (factor XIIa). This inhibition limits inflammation, vascular permeability, and edema formation. Mutations in SERPING1 cause hereditary angioedema, characterized by episodic swelling due to uncontrolled bradykinin production. C1-INH is targeted therapeutically in hereditary angioedema and investigated as a biomarker in cardiovascular and inflammatory conditions

Other names
C1 inhibitorC1-INHplasma protease C1 inhibitorserpine1
02

Mechanism of action

Replacement therapy: replenishes functional C1 inhibitor to restore regulation of complement and kallikrein/bradykinin pathways. Inhibition of bradykinin-mediated vascular leakage. Inhibition of plasma kallikrein/factor XIIa activity via irreversible binding ("suicide substrate" mechanism).

03

Biological functions

Regulates complement cascade (classical pathway)Controls inflammation (inhibits bradykinin production)Maintains vascular permeabilityLimits production of vasoactive peptides (e.g., bradykinin)Immune response (prevents excessive activation of complement)
04

Disease associations

Hereditary angioedema (due to C1 inhibitor deficiency; types I and II)InflammationCardiovascular disease (biomarker for poor coronary collateral circulation)
05

Safety considerations

Risk of hypersensitivity or allergic reactions to replacement therapiesRisk of thrombosis associated with C1-INH concentratesPotential for viral transmission with plasma-derived products
06

Interacting drugs

C1-INH replacement products (e.g., Berinert, Cinryze, Ruconest)

2 more in the full profile.

07

Biomarkers

C1 inhibitor level and function (diagnosis and monitoring of hereditary angioedema)Plasma bradykinin

Beyond the preview

Go deeper on Serpin family G member 1 (SERPING1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serpin family G member 1 (SERPING1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call